Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function
- 9 April 2004
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 173 (3-4) , 249-263
Abstract
The majority of experimental and clinical studies on the pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) tend to focus on its action on 5-HT biochemistry and function. However, there is considerable evidence for MDMA having marked acute effects on dopamine release. Furthermore, while MDMA produces long-term effects on 5-HT neurones in most species examined, in mice its long-term effects appear to be restricted to the dopamine system. The objective of this review is to examine the actions of MDMA on dopamine biochemistry and function in mice, rats, guinea pigs, monkeys and humans. MDMA appears to produce a major release of dopamine from its nerve endings in all species investigated. This release plays a significant role in the expression of many of the behaviours that occur, including behavioural changes, alterations of the mental state in humans and the potentially life-threatening hyperthermia that can occur. While MDMA appears to be a selective 5-HT neurotoxin in most species examined (rats, guinea pigs and primates), it is a selective dopamine neurotoxin in mice. Selectivity may be a consequence of what neurotoxic metabolites are produced (which may depend on dosing schedules), their selectivity for monoamine nerve endings, or the endogenous free radical trapping ability of specific nerve endings, or both. We suggest more focus be made on the actions of MDMA on dopamine neurochemistry and function to provide a better understanding of the acute and long-term consequences of using this popular recreational drug.Keywords
This publication has 179 references indexed in Scilit:
- Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?Neuroscience Letters, 2002
- Enhancement of Cocaine-Induced Hyperthermia Fails to Elicit NeurotoxicityNeurotoxicology and Teratology, 1998
- MDMA induced dopamine release in vivo: role of endogenous serotoninJournal of Neural Transmission, 1997
- Effects of Intracerebroventricular Administration of 5-(Glutathion-S-yl)-α-methyldopamine on Brain Dopamine, Serotonin, and Norepinephrine Concentrations in Male Sprague-Dawley RatsChemical Research in Toxicology, 1996
- Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic miceSynapse, 1995
- Enzymic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomesChemical Research in Toxicology, 1992
- Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine]Chemical Research in Toxicology, 1992
- Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the ratNeuroscience Letters, 1989
- Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administrationBrain Research, 1988
- Sodium‐Sensitive Cocaine Binding to Rat Striatal Membrane: Possible Relationship to Dopamine Uptake SitesJournal of Neurochemistry, 1983